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How to write a research paperIt is not an easy task to perform and report a good study
or review, and therefore quite a number of papers have been
published on presenting and explaining guidelines on how
to optimally do this. In line with this topic, it is also useful
to pay attention to the craft of writing a scientific paper in
general. Indeed, even if a study has been appropriately con-
ducted and technically well presented, it may have been
written in such a way that its message will not be recog-
nized [1,2]. In this issue, after an introductory paper by
Kotz et al, Kotz and Cals publish the first of a series of
monthly compact one-page papers, each highlighting an es-
sential step in preparing and writing a research paper. This
series, containing a total of 12 one-pagers, originates from
a PhD student course organized at Maastricht University,
and is especially recommended to young investigators
who would appreciate efficient guidance based on extensive
practical teaching experience. But senior authors may also
find useful writing tips in this series.
Diagnostic and prognostic research is a major topic in
this issue. In a Commentary, Weiss analyzes the opportuni-
ties and challenges in studying the relationship between test
results and the effectiveness of treatment. The author pres-
ents a broad methodologic overview, including both clinical
epidemiological and ethical issues. Austin and his group
compared the performance of conventional classification
and regression trees, including logistic regression, with
modern flexible tree-based methods from the data-mining
and machine-learning literature, in predicting and classify-
ing heart failure (HF) patients according to subtypes. It
turned out that each of these two approaches had specific
strong points in different classification tasks. Data-
analytic work on diagnostic performance has also been con-
ducted by Spruijt et al, who studied how vital signs such as
heart and respiratory rates should be included in clinical
prediction models for serious bacterial infections in febrile
children. Using data from a large prospective observational
study of febrile children, they compared various ways to
handle these rates as predictors, and concluded that main-
taining them as continuous variables results in a better pre-
dictive ability than dichotomization. Simel and co-authors
present a simple method to calculate sensitivity, specificity,
and likelihood ratios when, in studies of diagnostic tests,
the odds ratios and marginal values in a 2  2 tables are
given. This can help to retain studies in meta-analyses of
characteristics of diagnostic tests when only the odds ratio
is reported.0895-4356  2013 Elsevier Inc.
http://dx.doi.org/10.1016/j.jclinepi.2013.01.007
Open access under CC BY-NC-ND license.The role of observational and experimental studies in
providing useful evidence for clinical practice is again ad-
dressed quite extensively. In a systematic review, Prasad
and co-workers studied the extent to which authors of re-
ports of observational studies make clinical recommenda-
tions based on their results. They found that, in many
cases, authors of papers on observational studies in leading
journals extrapolate their results to make recommendations
for medical practice without first calling for a randomized
controlled trial. Another systematic review, conducted by
Glenton and colleagues from the Cochrane Effective Prac-
tice and Organisation of Care Group (EPOC), studied the
degree to which reviews considered non-randomized stud-
ies. The conclusion is that EPOC reviews mostly identified
non-randomized studies, but the proportion of non-
randomized studies varied strongly with the review topic.
The authors discuss possible implications of this finding
in relation to risk of bias in various intervention types.
Kim et al developed and tested the Risk of Bias Assessment
Tool for Non-randomized Studies (RoBANS), and evalu-
ated the validity of this instrument using non-randomized
studies from various systematic reviews. RoBANS was
shown to have moderate reliability and promising feasibil-
ity and validity. Further evaluation and refinement of the
tool is recommended.
In view of the concern that noninferiority (NI) trials may
pose a risk of degradation of the efficacy of available treat-
ments, Gladstone and Vach reviewed data from registered
trials to determine the fraction of positive true effects and
the average true effect of current NI trials. Their findings
suggest that the current practice of choosing NI designs
makes degradation on average unlikely, but in some trials
the newly tested treatments are distinctly inferior to stan-
dard treatments.
Two systemic reviews focus on issues related to drug
interventions. Haidich et al evaluated the extent to which
meta-analyses of drugs and biologics focused only on one
specific agent. Indeed, they found that most meta-analyses
did not consider all the available comparisons of tested inter-
ventions for a given condition, and that the scope of meta-
analysis is frequently limited to particular agents. Industry
sponsoring was an important determinant of such a narrow
focus. More inclusive reviews andmeta-analyses are encour-
aged. A review conducted by Sale and her team studied the
methods applied to calculate reported medication initiation
rates in fracture secondary prevention programs. It was
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that prevented useful comparison of the programs under
study. Therefore, the authors propose a three-item guideline
for reporting of medication initiation of postfracture inter-
ventions. At the other side of the medication spectrum, not
initiation but cumulation of (chronic) drug use, that is, poly-
pharmacy, is an important phenomenon to be studied. In two
letters to the editors, Lai and Liao and Gnjidic et al, respec-
tively, discuss the definition of polypharmacy also in relation
to adverse outcomes.
In studying the impact of public health interventions, it is
often important how effects that have been established in
a study population can be extrapolated to other populations.
Based on data froma hypertension intervention program study
among elderly subjects, Charvat and co-authors describe
a method to assess the impact of blood pressure reduction on
the occurrence of stroke in another target population account-
ing for age, and they discuss the implications of this method.
The importance of choosing the appropriate level of
study and analysis has been recognized for a long time
[3], but evaluations of the extent of the actual difference
in outcomes of studies using different levels are scarce.
Marcucci et al compared the performance of aggregate data
(AD)-based and individual patient data (IPD)-based meta-
analyses of the same set of studies on the observed ability
of D-dimer to detect recurrence risk in venous thromboem-
bolism patients. It was concluded that both meta-analyses
yielded similar results. However, the often more resource-
intensive IPD approach can be justified by the need to
investigate sources of heterogeneity. Multilevel analyses
allow the evaluation of the effects of various determinants
simultaneously working at different levels, as was studied
by Rigal et al. The authors analyzed the participation of pa-
tients in a survey about prevention in relation to medical,
social, and practice characteristics. This approach revealedinteresting insights, especially in the impact of practice
organizational aspects.
In another context, between-practice variation was also
an important topic in a study by Carey et al. Based on
a large retrospective primary care cohort study, they derived
a simple nine-item QOF (Quality and Outcomes Frame-
work) score from routinely recorded chronic conditions in
primary care, and assessed its predictive performance as
to 1-year mortality. The authors report that the QOF scores
performed better than the Charlson Index in predicting
mortality and explaining between practice variations, and
suggest that it can be used for improving risk-adjusted com-
parisons of performance and outcomes between primary
care providers.
For conducting avalid cohort study, attrition should bemin-
imal and non-selective. Using data from a large chronic dis-
ease and risk factor cohort study, Taylor and co-workers
show that weighing of data and analytical approaches may ac-
count for differences and help to overcome inadequate repre-
sentativeness in a maturing prospective observational study.
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